In This Issue
Are the Reported Clinical Outcomes with Stereotactic Ablative Radiotherapy Generalizable?
Health-Related Quality of Life and Utility in Patients with Advanced Non–Small-Cell Lung Cancer
Detection of ALK-Positive Non–Small-Cell Lung Cancers on Cytological Specimens
Pyrosequencing Analysis of EGFR and KRAS Mutations in EUS and EBUS-Derived Cytologic Samples of Adenocarcinomas of the Lung
New Methods for ALK Status Diagnosis in Non–Small-Cell Lung Cancer
Interleukin-22 Is Frequently Expressed in Small- and Large-Cell Lung Cancer and Promotes Growth in Chemotherapy-Resistant Cancer Cells
A Pooled Analysis of Limited-Stage Small-Cell Lung Cancer Patients Treated with Induction Chemotherapy Followed by Concurrent Platinum-Based Chemotherapy and 70 Gy Daily Radiotherapy
Safety and Efficacy of Stereotactic Body Radiotherapy for Stage I Non–Small-Cell Lung Cancer in Routine Clinical Practice
Tumor Volume Decrease at 8 Weeks Is Associated with Longer Survival in EGFR-Mutant Advanced Non–Small-Cell Lung Cancer Patients Treated with EGFR TKI
Erlotinib Versus Gefitinib for Control of Leptomeningeal Carcinomatosis in Non–Small-Cell Lung Cancer
Vandetanib Plus Chemotherapy for Induction Followed by Vandetanib or Placebo As Maintenance for Patients with Advanced Non–Small-Cell Lung Cancer
Phase II Trial of Neoadjuvant Bevacizumab Plus Chemotherapy and Adjuvant Bevacizumab in Patients with Resectable Nonsquamous Non–Small-Cell Lung Cancers
A Phase II Study of the Histone Deacetylase Inhibitor Panobinostat (LBH589) in Pretreated Patients with Small-Cell Lung Cancer
Brief Report on the Use of Radiolabeled Somatostatin Analogs for the Diagnosis and Treatment of Metastatic Small-Cell Lung Cancer Patients
EZH2 Promotes E2F-Driven SCLC Tumorigenesis through Modulation of Apoptosis and Cell-Cycle Regulation
Impact of PET Staging in Limited-Stage Small-Cell Lung Cancer
Giant Malignant Granular Cell Tumor (GCT) of the Posterior Mediastinum
Pulmonary Adenocarcinoma in a Young Patient of Pulmonary Langerhans Cell Histiocytosis (PLCH)
Abscopal Effects after Conventional and Stereotactic Lung Irradiation of Non–Small-Cell Lung Cancer
Successful Crizotinib Retreatment after Crizotinib-Induced Interstitial Lung Disease
Transformation to Sarcomatoid Carcinoma in ALK-Rearranged Adenocarcinoma, Which Developed Acquired Resistance to Crizotinib and Received Subsequent Chemotherapies
Why Denosumab Obtains a Survival Benefit over Zoledronic Acid in Bone Metastatic Lung Cancer Patients?
“One Marker Does Not Fit All”
The Issue of Studies Evaluating Biomarkers Which Predict Outcome after Pemetrexed-Based Chemotherapy in Malignant Pleural Mesothelioma